We are live on ! Find out more
CIA

Capital Impact Advisors Portfolio holdings

AUM $247M
1-Year Est. Return 31.15%
This Fund
S&P 500
This Quarter Est. Return
-3.32%
1 Year Est. Return
+31.15%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$262M
AUM Growth
-$10.5M
Cap. Flow
+$1.89M
Cap. Flow %
0.72%
Top 10 Hldgs %
18.95%
Holding
132
New
7
Increased
58
Reduced
39
Closed
13

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$4.91M
2
IONS icon
Ionis Pharmaceuticals
IONS
+$2.51M
3
PAYC icon
Paycom
PAYC
+$2.07M
4
KKR icon
KKR & Co
KKR
+$2.04M
5
UTHR icon
United Therapeutics
UTHR
+$1.83M

Sector Composition

Rank Sector Weight
1 Technology 28.24%
2 Healthcare 23.73%
3 Communication Services 9.87%
4 Financials 9.16%
5 Consumer Discretionary 9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMZN icon
1
Amazon
AMZN
$2.69T
$8.57M 3.26%
99,300
-5,780
-6% -$536K
META icon
2
Meta Platforms (Facebook)
META
$1.64T
$5.86M 2.23%
33,073
-3,202
-9% -$609K
GOOGL icon
3
Alphabet (Google) Class A
GOOGL
$4.3T
$5.75M 2.19%
93,880
-34,680
-27% -$2.05M
MSFT icon
4
Microsoft
MSFT
$2.99T
$4.92M 1.87%
+35,722
New +$4.91M
AAPL icon
5
Apple
AAPL
$4.8T
$4.75M 1.81%
86,840
-2,356
-3% -$123K
UTHR icon
6
United Therapeutics
UTHR
$22.5B
$4.19M 1.6%
51,810
+22,714
+78% +$1.83M
IPGP icon
7
IPG Photonics
IPGP
$4.16B
$4.04M 1.54%
30,401
+11,249
+59% +$1.49M
STLD icon
8
Steel Dynamics
STLD
$33.2B
$3.96M 1.51%
134,931
+35,912
+36% +$1.06M
SSNC icon
9
SS&C Technologies
SSNC
$16.7B
$3.92M 1.5%
77,427
+26,225
+51% +$1.34M
VEEV icon
10
Veeva Systems
VEEV
$32.1B
$3.78M 1.44%
25,240
-5,778
-19% -$927K
IONS icon
11
Ionis Pharmaceuticals
IONS
$8.75B
$3.69M 1.41%
62,434
+38,568
+162% +$2.51M
PAYC icon
12
Paycom
PAYC
$6.98B
$3.43M 1.31%
16,631
+8,859
+114% +$2.07M
RNG icon
13
RingCentral
RNG
$3.42B
$3.29M 1.25%
26,522
-8,750
-25% -$1.15M
NVDA icon
14
NVIDIA
NVDA
$4.92T
$3.03M 1.15%
704,800
CRM icon
15
Salesforce
CRM
$142B
$2.99M 1.14%
20,165
-10,670
-35% -$1.62M
OLLI icon
16
Ollie's Bargain Outlet
OLLI
$4.08B
$2.87M 1.09%
48,009
+22,209
+86% +$1.67M
NFLX icon
17
Netflix
NFLX
$285B
$2.76M 1.05%
104,760
-60,720
-37% -$1.9M
ISRG icon
18
Intuitive Surgical
ISRG
$125B
$2.68M 1.02%
15,057
+4,095
+37% +$708K
NSP icon
19
Insperity
NSP
$1.97B
$2.48M 0.94%
25,283
+5,280
+26% +$573K
TXRH icon
20
Texas Roadhouse
TXRH
$12.9B
$2.44M 0.93%
46,776
+5,434
+13% +$288K
CMG icon
21
Chipotle Mexican Grill
CMG
$42.5B
$2.42M 0.92%
147,850
-63,900
-30% -$1.02M
AKAM icon
22
Akamai
AKAM
$17.9B
$2.42M 0.92%
26,925
+2,033
+8% +$176K
GBT
23
DELISTED
Global Blood Therapeutics, Inc.
GBT
$2.37M 0.9%
48,155
+8,289
+21% +$432K
CORT icon
24
Corcept Therapeutics
CORT
$9.83B
$2.37M 0.9%
162,544
-20,926
-11% -$257K
ICE icon
25
Intercontinental Exchange
ICE
$80.1B
$2.36M 0.9%
25,524
-11,725
-31% -$1.07M

Similar funds

Capital Impact Advisors's Q3 2019 Portfolio in Review

As of Q3 2019, Capital Impact Advisors held 132 positions worth $262M, down 3.8% from $273M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Capital Impact Advisors's Q3 2019 filing shows 7 new, 58 increased, 39 reduced and 13 closed positions. Its largest new stake was Microsoft: 35,722 shares worth $4.92M. The largest sale was UnitedHealth, an estimated $3.21M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Healthcare and Communication Services.

  • Capital Impact Advisors's largest Q3 2019 buy was Microsoft: 35,722 shares worth $4.92M.
  • Capital Impact Advisors added most to Ionis Pharmaceuticals in Q3 2019, an estimated $2.51M increase.
  • Capital Impact Advisors's biggest Q3 2019 reduction was Alphabet (Google) Class A, cutting an estimated $2.05M.
  • Capital Impact Advisors fully exited UnitedHealth in Q3 2019, selling an estimated $3.21M.
  • Capital Impact Advisors's ten largest holdings make up 19% of its $262M portfolio in Q3 2019.
  • Capital Impact Advisors opened 7 new positions and closed 13 in Q3 2019.
  • Capital Impact Advisors's portfolio value fell 3.8% quarter-over-quarter to $262M.

Based on Capital Impact Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.